ScholarIQanswers from OpenAlex & ORCID
François Guilhot
ResearcherPublications, citations & collaboration network
François Guilhot is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does François Guilhot have?
ScholarIQindexed works
François Guilhot has 588 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does François Guilhot have?
ScholarIQcitation count
François Guilhot has 41,972 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of François Guilhot?
ScholarIQh-index
François Guilhot has an h-index of 82 in OpenAlex.
What is the i10-index of François Guilhot?
ScholarIQi10-index
François Guilhot has an i10-index of 282 in OpenAlex.
What is the ORCID of François Guilhot?
ScholarIQorcid
The ORCID for François Guilhot is on the source record.
What is the OpenAlex record for François Guilhot?
ScholarIQopenalex
The OpenAlex for François Guilhot is on the source record.
What are the most-cited papers on François Guilhot?
ScholarIQmost cited works
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Andreas Hochhaus, Michele Baccarani, Richard T. Silver, CA Schiffer, Jane F. Apperley, Francisco Cervantes, R E Clark, J. E. Cortes, Michael W. Deininger, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, J. Janssen, Hagop M. Kantarjian, D. W. Kim, Richard A. Larson, J. H. Lipton, F.-X. Mahon, Jiří Mayer, Franck E. Nicolini, D Niederwieser, Fabrizio Pane, Jerald P. Radich, Delphine Réa, Johan Richter, G Rosti, Philipe Rousselot, Giuseppe Saglio, Susanne Saußele, Simona Soverini, J. L. Steegmann, Anna Turkina, Andrey Zaritskey, R. Hehlmann
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
Susanne Saußele, Johan Richter, Joëlle Guilhot, Franz Gruber, Henrik Hjorth-Hansen, António Almeida, Jeroen J. W. M. Janssen, Jiřı́ Mayer, Perttu Koskenvesa, Panayiotis Panayiotidis, Ulla Olsson‐Strömberg, Joaquín Martínez‐López, Philippe Rousselot, Hanne Vestergaard, Hans Ehrencrona, Veli Kairisto, Kateřina Machová Poláková, Martin C. Müller, Satu Mustjoki, Marc Berger, Alice Fabarius, Wolf‐Karsten Hofmann, Andreas Hochhaus, Markus Pfirrmann, François‐Xavier Mahon, Gert J. Ossenkoppele, Maria Pagoni, Stina Söderlund, Martine Escoffre‐Barbe, Gabriel Étienne, Jolanta Dengler, Françoise Huguet, Nikolas von Bubnoff, Hana Klamová, Edgar Faber, François Guilhot, Kourosh Lotfi, Delphine Réa, Tim H. Brümmendorf, G.E. de Greef, Leif Stenke, Franck E. Nicolini, Laurence Legros, Andreas Burchert, J Voglová, Aude Charbonnier, Emmanuel Gyan, Volker Kunzmann, Peter E. Westerweel
Quality of Life in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia on Imatinib Versus Interferon Alfa Plus Low-Dose Cytarabine: Results From the IRIS Study
Elizabeth A. Hahn, G. Alastair Glendenning, Mark Sorensen, Stacie Hudgens, Brian Druker, François Guilhot, Richard A. Larson, Stephen G. O’Brien, Deborah Dobrez, Martee L. Hensley, David Cella